Overview

This trial is active, not recruiting.

Condition impaired renal function
Treatment ischemic preconditioning
Sponsor University of Cologne
Start date July 2012
End date December 2012
Trial size 81 participants
Trial identifier NCT01760031, RenPro1L

Summary

Remote ischemic preconditioning reduces the incidence of contrast-induced acute kidney injury in patients undergoing elective coronary angiography. This study was designed to acquire long-term data of initially randomized patients in the RenPro Trial.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
Arm
Subjects with baseline impaired renal function undergoing cardiac catheterization with contrast-medium exposure
ischemic preconditioning
Subjects received ischemic preconditioning previous to cardiac catheterization

Primary Outcomes

Measure
MACCE
time frame: 1 Year

Secondary Outcomes

Measure
Renal function
time frame: 1 year

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

All patients who participated to the RenPro trial

Additional Information

Official title Remote Preconditioning for Contrast-Induced Acute Kidney Injury: Long-Term Follow up (RenPro Longterm)
Principal investigator Fikret Er, MD
Description Data of the RenPro Trial has been already published. In the present study data of longterm follow up are collected.
Trial information was received from ClinicalTrials.gov and was last updated in December 2012.
Information provided to ClinicalTrials.gov by University of Cologne.